PE firms keen on investing $3-4 billion in intermediate pharma companies: Report

PE firms keen on investing $3-4 billion in intermediate pharma companies: Report Overseas private PE players have prepared a war chest of $3-4 billion to inject capital into intermediate pharmaceutical companies in India after investing nearly $1.5 billion since the COVID-19 pandemic began.

No comments:

Post a Comment